Announcement only states that all patients reached 28 days (from date of treatment) without experiencing dose limiting toxicity.
So no positive status updates (not that we would be expecting them at this stage) on any of the patients unfortunately.
- Forums
- ASX - By Stock
- CHM
- Ann: Successful Completion of First Patient Cohort Phase 1 Trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: Successful Completion of First Patient Cohort Phase 1 Trial, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 4817793 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18563373 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4817793 | 0.004 |
40 | 27029271 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18563373 | 21 |
0.006 | 13384684 | 15 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online